Allergan Asks Fed. Circ. For Block On Generic Zymaxid

Law360, New York (September 11, 2013, 5:07 PM EDT) -- Allergan Inc. and two other pharmaceutical companies asked the Federal Circuit on Tuesday to issue an injunction to prevent rivals Lupin Ltd. and Hi-Tech Pharmacal Co. Inc. from marketing a generic version of Allergan's pinkeye medication Zymaxid, seeking to reclaim their patent on the drug. 

Allergan, Senju Pharmaceutical Co. Ltd. and Kyorin Pharmaceutical Co. Ltd filed a notice of appeal on Monday after a Delaware federal court decided in August that while Lupin and Hi-Tech infringed on the plaintiffs' patents, those patents are invalid on the basis...
To view the full article, register now.